Search

Your search keyword '"Gunduz, U. R."' showing total 5 results
Start Over Author "Gunduz, U. R."
5 results on '"Gunduz, U. R."'

1. Platelet function parameters in management of hepatic hydatid disease: A case-controlled study

Author

Dinc, B., Dusen, S., Ay, N., Dinc, S. E., Mayir, B., Gunduz, U. R., Musri, O. C., Bas, B., Dogan, U., and Alten Oskay

Subjects
hematocrit, retrospective study, thrombocyte count, postoperative period, thrombocyte function and characteristics, Article, male, Disease management, thrombocyte function, blood clotting parameters, platelet distribution width, controlled study, eosinophil, preoperative care, human, Platelet function test, Moroccan pepper virus, adult, liver hydatid cyst, case control study, major clinical study, Hepatic hydatid cysts, aged, female, thrombocyte volume, sensitivity and specificity, Original Article
Abstract

Aim: To evaluate platelet function in patients with a history of surgical treatment for hepatic hydatid disease (HD). Methods: This retrospective case-controlled study was performed in a state hospital in Turkey from January 2009 to November 2013. The patients were divided into two groups: those evaluated in the preoperative period (Group 1) and those evaluated in the postoperative period (Group 2). The patient groups were compared with a control group (Group 3). All three groups were evaluated using laboratory records from day 1 of the preoperative period and day 30 of the postoperative period. The haematocrit level (HTC), platelet count (PLT), mean platelet volume (MPV), platelet distribution width (PDW), and percentage of eosinophils (EOS) were compared among the groups. Results: Fifty-three patients who had undergone surgical treatment of hepatic HD and 55 healthy controls were included in the study. The mean follow-up time for all patients was 45 (14-70) months. The patients comprised 33 (62%) females and 20 (38%) males. The control group comprised 37 (67%) females and 18 (33%) males. The median age of the patients was 48 (19-78) years, while that of the control group was 42 (16-64) years. No significant differences in the HTC, PLT, or EOS were present among the groups. The MPV and PDW indicated that platelet function was significantly different between Group 1 and Groups 2 and 3. Additionally, nine patients had undergone previous surgical treatment for HD. In a separate long-term follow-up, these patients exhibited no statistically significant differences in MPV or PDW between the preoperative and postoperative periods. Conclusions: MPV and PDW can be used in the initial follow-up of patients with hepatic HD, but have limited use in long-term follow-up. © 2015, Int J Clin Exp Med. All rights reserved.

Published
2015

4. Erratum:Preoperative neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio as new prognostic factors for patients with colorectal cancer.

Author

Sevinc MM, Gunduz UR, Kinaci E, Aydin AA, Bayrak S, Gursu RU, and Gunduz S

Abstract

In this article published in Volume 21, issue 5, the authors' names appeared in the Pubmed abstract as: "Mahsuni Sevinc M, Riza Gunduz U, Kinaci E, Armagan Aydin A, Bayrak S, Umar Gursu R, Gunduz S". The correct authors' names are: "Sevinc MM, Gunduz UR, Kinaci E, Aydin AA, Bayrak S, Gursu RU, Gunduz S" This error appeared only in the PubMed database and not in the print form of the Journal.

Published
2016

5. The efficacy of intravenous hyoscine-N-butylbromide during colonoscopy: a prospective, randomized, double-blind, placebo-controlled study.

Author

Dinc B, Gunduz UR, Bas B, Ay N, Koc U, Oner OZ, and Gomceli I

Subjects
Adolescent, Adult, Aged, Colitis diagnosis, Colonic Neoplasms diagnosis, Colonic Polyps diagnosis, Diverticulum, Colon diagnosis, Double-Blind Method, Female, Humans, Male, Middle Aged, Operative Time, Young Adult, Butylscopolammonium Bromide therapeutic use, Colonoscopy methods, Parasympatholytics therapeutic use, Premedication methods, Spasm prevention & control
Abstract

Background: Colonic spasm makes colonoscope advancement difficult. This prospective, randomized, double-blind, placebo-controlled study aimed to evaluate the efficacy of hyoscine-N-butylbromide as an antispasmodic during colonoscopy., Method: Patients referred for elective colonoscopy were randomized into the study and placebo groups. Before the procedure, the study and placebo groups received 20 mg intra-venous hyoscine-N-butylbromide and intravenous saline solution of the same amount, respectively. Demographic and procedure--related data were recorded and compared between the groups., Results: Of 198 patients referred for elective colonoscopy, 121 were included (study group = 60, placebo group = 61). No differences were observed between the study and placebo groups in terms of demographic data, pre-procedure characteristics, and colonoscopic characteristics including the cecal intubation time, total procedure time, bowel preparation, sedation doses, hemo-dynamic findings, endoscopist satisfaction, patient comfort, and polyp detection rate. The only difference was an increase in the heart rate by 32% in the study group after hyoscine-N-butyl-bromide administration (p < 0.001)., Conclusions: Hyoscine-N-butylbromide did not reduce the time to reach the cecum and the total colonoscopy time, and patient and endoscopist satisfaction and polyp detection rate did not change. Furthermore, it was concluded that hyoscine-N-butylbromide can increase the risk of drug-related complications., (© Acta Gastro-Enterologica Belgica.)

Published
2016

Catalog

Books, media, physical & digital resources
See catalog results